Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Kimball

Showing results (211-220 of 373) with videos related to

Pageof 38
Sort By:
The British Journal of Dermatology|March 24, 2021
Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey studyL M Prens, M L Porter, K T Savage, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|September 3, 2019
Sialic acid on avian erythrocytesMark D Jankowski, Scott R Glaberman, David B Kimball, et al.
Journal of the American Academy of Dermatology|June 12, 2020
Psoriasis: Knowledge, attitudes and perceptions among primary care providersSandeep Kumar, Kelsey Flood, Nicole M Golbari, et al.
Journal of the American Academy of Dermatology|May 23, 2018
Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trialsAlexandra B Kimball, Murali Sundaram, Alan L Shields, et al.
Journal of Nanoscience and Nanotechnology|October 10, 2006
High throughput growth of zinc oxide nanowires from zinc powder with the assistance of sodium chlorideJian Yang, Wenzhong Wang, Yi Ma, et al.
The British Journal of Dermatology|November 21, 2013
Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09A B Kimball, J Schenfeld, N A Accortt, et al.
Archives of Dermatology|February 20, 2008
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Acta Dermato-Venereologica|August 8, 2018
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and IIAlexandra B Kimball, Thrasivoulos Tzellos, Brian M Calimlim, et al.
The British Journal of Dermatology|August 13, 2015
Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United StatesA B Kimball, J Schenfeld, N A Accortt, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Pageof 38

Showing results (211-220 of 373) with videos related to

Sort By:
Pageof 38
The British Journal of Dermatology|March 24, 2021
Hidradenitis suppurativa disease course during pregnancy and postpartum: a retrospective survey studyL M Prens, M L Porter, K T Savage, et al.
Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology|September 3, 2019
Sialic acid on avian erythrocytesMark D Jankowski, Scott R Glaberman, David B Kimball, et al.
Journal of the American Academy of Dermatology|June 12, 2020
Psoriasis: Knowledge, attitudes and perceptions among primary care providersSandeep Kumar, Kelsey Flood, Nicole M Golbari, et al.
Journal of the American Academy of Dermatology|May 23, 2018
Adalimumab alleviates skin pain in patients with moderate-to-severe hidradenitis suppurativa: Secondary efficacy results from the PIONEER I and PIONEER II randomized controlled trialsAlexandra B Kimball, Murali Sundaram, Alan L Shields, et al.
Journal of Nanoscience and Nanotechnology|October 10, 2006
High throughput growth of zinc oxide nanowires from zinc powder with the assistance of sodium chlorideJian Yang, Wenzhong Wang, Yi Ma, et al.
The British Journal of Dermatology|November 21, 2013
Incidence rates of malignancies and hospitalized infectious events in patients with psoriasis with or without treatment and a general population in the U.S.A.: 2005-09A B Kimball, J Schenfeld, N A Accortt, et al.
Archives of Dermatology|February 20, 2008
Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Acta Dermato-Venereologica|August 8, 2018
Achieving Hidradenitis Suppurativa Response Score is Associated with Significant Improvement in Clinical and Patient-reported Outcomes: Post Hoc Analysis of Pooled Data From PIONEER I and IIAlexandra B Kimball, Thrasivoulos Tzellos, Brian M Calimlim, et al.
The British Journal of Dermatology|August 13, 2015
Cohort study of malignancies and hospitalized infectious events in treated and untreated patients with psoriasis and a general population in the United StatesA B Kimball, J Schenfeld, N A Accortt, et al.
Journal of the American Academy of Dermatology|December 15, 2010
Efficacy and safety of ABT-874, a monoclonal anti-interleukin 12/23 antibody, for the treatment of chronic plaque psoriasis: 36-week observation/retreatment and 60-week open-label extension phases of a randomized phase II trialAlexa B Kimball, Kenneth B Gordon, Richard G Langley, et al.
Pageof 38